-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ION-547 in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-547 in Thrombosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ION-547 in Thrombosis Drug Details: ION-547 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-547 in Uremic (Renal) Pruritus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-547 in Uremic (Renal) Pruritus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-547 in Uremic (Renal) Pruritus Drug Details: EP-547 is under developmant...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-547 in Hepatitis B
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EP-547 in Hepatitis B Drug Details: EP-547 is under developmant for the treatment of cholestatic pruritus...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-547 in Pruritus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EP-547 in Pruritus Drug Details:EP-547 is under developmant for the treatment of cholestatic pruritus due to primary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-547 in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-547 in Thrombosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ION-547 in Thrombosis Drug Details:ION-547 is under development for the treatment of thrombosis. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Post-Traumatic Stress Disorder (PTSD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Post-Traumatic Stress Disorder (PTSD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Post-Traumatic Stress Disorder (PTSD) Drug Details: Brexanolone (Zulresso)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Alcohol Dependence
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Alcohol Dependence report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Alcohol Dependence Drug Details: Brexanolone (Zulresso) is a mixture of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Tinnitus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Tinnitus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Tinnitus Drug Details: Brexanolone (Zulresso) is a mixture of allopregnanolone and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Povorcitinib Phosphate in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povorcitinib Phosphate in Hidradenitis Suppurativa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povorcitinib Phosphate in Hidradenitis Suppurativa Drug Details: Povorcitinib (INCB-54707) is under...